NeuroVive Pharmaceutical ABの資産のリターン
NeuroVive Pharmaceutical ABの資産のリターン は何ですか。
NeuroVive Pharmaceutical ABの資産のリターン は-82.51%です。
資産のリターン の定義は何ですか。
資産のリターンは 、企業の資産が収益を生み出す際の収益性を示します。純利益を平均総資産で除して計算されます。
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
OTCのセクタHealth Careにおける資産のリターン の企業と比べるNeuroVive Pharmaceutical AB
NeuroVive Pharmaceutical ABは何をしますか。
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
NeuroVive Pharmaceutical ABと類似の資産のリターン
- NxGoldの資産のリターン は-83.04%です。
- China Environmental Technologyの資産のリターン は-82.87%です。
- Cue Biopharma Incの資産のリターン は-82.85%です。
- Loop Industries Incの資産のリターン は-82.70%です。
- Desktop Metalの資産のリターン は-82.70%です。
- Gritstone Bio Incの資産のリターン は-82.53%です。
- NeuroVive Pharmaceutical ABの資産のリターン は-82.51%です。
- Flow Beverageの資産のリターン は-82.42%です。
- NOXXON Pharma NVの資産のリターン は-82.39%です。
- Amesiteの資産のリターン は-82.39%です。
- KalVista Pharmaceuticals Incの資産のリターン は-82.39%です。
- Edgewater Wireless Systemsの資産のリターン は-82.38%です。
- ProShares Managed Futures Strategyの資産のリターン は-82.18%です。